Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00049348 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00049348: Completed Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
NCT00049348 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00049348, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Randomized phase II trial to compare the effectiveness of two different regimens combining chemotherapy with radiation therapy in treating patients who are undergoing surgery for locally advanced pancreatic cancer.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- BIOLOGICAL filgrastim
- BIOLOGICAL epoetin alfa
- DRUG gemcitabine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-10-13 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
What the finished NCT00049348 record still lists
NCT00049348 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00049348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00049348 about?
NCT00049348 is a clinical study titled "Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy before surgery may shrink the tumor so that it can be removed during ...
What is the current status of trial NCT00049348?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-10-13. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00049348?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), filgrastim (BIOLOGICAL), epoetin alfa (BIOLOGICAL), gemcitabine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00049348?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI